Australasian Gastro-Intestinal Trials Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Camperdown Australia (2000)

Organization Overview

First Clinical Trial
2000
NCT00006479
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

AGITG | AGITG Australasian Gastro Intestinal Trials Group | Australasian Gastro-Intestinal Trials Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anus Neoplasms (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Neuroendocrine (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Cholangiocarcinoma (Phase 3)

Colorectal Neoplasms (Phase 3)

Esophageal Neoplasms (Phase 3)

Gallbladder Neoplasms (Phase 3)

Gastrointestinal Stromal Tumors (Phase 3)

Neoplasm Metastasis (Phase 3)

Neoplasms (Phase 2)

Neuroendocrine Tumors (Phase 2)

Pancreatic Neoplasms (Phase 3)

Stomach Neoplasms (Phase 3)

Urinary Bladder Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 17
  • # of Trial APIs: 29